Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different Anti-Ischemic Treatments in Coronary Heart Disease Undergoing PCI
ChiCTR-PPC-16009032Phase 4Recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in coronary arteriosclerosis comparing Control: aspirin + clopidogrel + heparin with Treatment: aspirin + ticagrelor + bivalirudin (2 arms). Primary endpoint: MACE. Started Aug 2016; status: recruiting.
02
Drugs
clopidogrelticagrelorheparinbivalirudinaspirin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-PPC-16009032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PPC-16009032.